JAGLX

Janus Henderson Global Life Sciences Fund Class T [JAGLX] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

JAGLX Stock Summary

Top 10 Correlated ETFs

JAGLX

Top 10 Correlated Stocks

JAGLX

In the News

JAGLX Financial details

Company Rating
-
Market Cap
5.37B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.05
Dividend %
0.07%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
0.76%
SMA50
3.8%
SMA100
-6.17%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
61.61-75.13
52W High
-12.91%
52W Low
+7.08%
RSI
46.62
Rel Volume
-
Avg Volume
-
Volume
Perf Week
-2.27%
Perf Month
0.86%
Perf Quarter
-8.5%
Perf Half Y
-8.61%
-
-
-
-
Beta
0.73
-
-
Volatility
0.6%, 0.62%
Prev Close
0.54%
Price
65.32
Change
0.54%

JAGLX Financial Performance

JAGLX Dividend History

JAGLX Frequently Asked Questions

What is Janus Henderson Global Life Sciences Fund Class T stock symbol ?

Janus Henderson Global Life Sciences Fund Class T is a US stock and trading under the symbol JAGLX

What is Janus Henderson Global Life Sciences Fund Class T stock quote today ?

Janus Henderson Global Life Sciences Fund Class T stock price is $65.32 today.

Is Janus Henderson Global Life Sciences Fund Class T stock public?

Yes, Janus Henderson Global Life Sciences Fund Class T is a publicly traded company.

Something similar

Top by Market Cap
AVGO
EMBASSY.NS
TL0.DE
MSFT
MSF.DE
Top Correlated ETFs
MEDI
BMED
PBE
FTXH
PILL
Top Correlated Stocks
MRK
IPSC
GRBK
Similar Market Cap
MRL.MC
RAA.DE
1866.HK
OPHLF
8260.T

Company Profile

Financial Services Asset Management - Global
  • Market Capitalization 5.37B
  • Headquarters US
  • IPO Date 1998-12-31

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.